A leading adviser to NICE has called for restrictions on the use of atorvastatin to be thrown aside after its price tumbled by 93% today, following the expiry of its patent.

Although metformin is the ‘gold standard’ treatment for diabetes, it has little effect on reducing the risk of death or cardiovascular disease, say the authors of two new analyses.

Including ECGs in routine cardiovascular risk assessments of older people would identify more patients at high risk of a coronary event, say US researchers.

GPs should consider carefully the increased risk of bleeding and stroke with newer antidepressants before prescribing them, say US researchers.

GPs should monitor older patients with dementia closely during in the first month of antipsychotic treatment, say researchers who found the drugs double the risk of a heart attack.

New online portal launches to help HCPs guide patients towards cardiovascular health

Sir John Oldham lays out the clinical, organisational and systemic reasons to commission more self-care and co-management schemes.

Dr Richard Blakey describes how his heart failure service – as part of a new quality improvement programme – reduced admissions and boosted diagnoses

Dr Karl Graham describes how his practice has used new technology to standardise the advice and recall times for patients taking warfarin

Recently-elected chair of the Primary Care Cardiovascular Society, Dr Kathryn Griffith, gives her views on NICE's recent chest pain guidance, GP commissioning and moves to downgrade the use of statins in diabetes

Dr Rohit Sethi explains how he used a short online questionnaire to assess the knowledge of his warfarin patients about their treatment – with shocking results.

This older lady with hypertension presented with acutely painful, swollen fingers on her right hand. Dr Mike Wyndham describes how he made the diagnosis

Cardiology GPSI Dr Rubin Minhas offers tips on making sure BP monitoring in your practice is as accurate as possible